Prof. Anselmi

Edwards Lifesciences at EACTS 2022: Aortic valve disease: Patient centric management in elderly population

Live Case filmed at Hezrklinik Hirslanden, with:

• Prof. Dr. Med. Jürg Grünenfelder
• PD Dr. Med. Patric Biaggi

Prof. Michael Borger

MVT Aortic 2022, vol.2

Alexey Dashkevich

MVT Aortic 2022, Vol.2

– Is the patient 50-65 years old? Be sure to think about re-intervention, keep the guidelines in mind, and fully inform the patient.

– Which type of anticoagulation therapy should be used?

– Don’t forget, a Ross procedure may be an option.

Prof. Augusto D’Onofrio

MVT Aortic 2022, vol.1

– Not only about hemodynamics, this lecture provides comparisons among three bioprostheses

– Similar clinical outcomes, better hemodynamic results, and shorter ICU stays for rapid deployment valves… but newer bioprosthesis tissue technology may raise the bar even higher

Prof. Marco Di Eusanio

MVT Aortic 2022, vol.1

Prof. Bart Meuris

MVT Aortic 2022, vol.1

• Shorter hospital stays, less anticoagulation, long-term financial savings? Hear about the data of an expert’s personal experience.

• With advanced anti-calcification treatment, the future of bioprostheses is promising not only for patient outcomes, but even from a financial perspective

Dr. Douglas Johnston

STS annual meeting 202